The emergence of top-down proteomics in clinical research
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Proteomic technology has advanced steadily since the development of 'soft-ionization' techniques for mass-spectrometry-based molecular identification more than two decades ago. Now, the large-scale analysis of proteins (proteomics) is a mainstay of biological research and clinical translation, with researchers seeking molecular diagnostics, as well as protein-based markers for personalized medicine. Proteomic strategies using the protease trypsin (known as bottom-up proteomics) were the first to be developed and optimized and form the dominant approach at present. However, researchers are now beginning to understand the limitations of bottom-up techniques, namely the inability to characterize and quantify intact protein molecules from a complex mixture of digested peptides. To overcome these limitations, several laboratories are taking a whole-protein-based approach, in which intact protein molecules are the analytical targets for characterization and quantification. We discuss these top-down techniques and how they have been applied to clinical research and are likely to be applied in the near future. Given the recent improvements in mass-spectrometry-based proteomics and stronger cooperation between researchers, clinicians and statisticians, both peptide-based (bottom-up) strategies and whole-protein-based (top-down) strategies are set to complement each other and help researchers and clinicians better understand and detect complex disease phenotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414 · cited 2×
“Although plasma is readily obtainable, it is daunting in its proteomic complexity, owing to a vast dynamic range of component concentrations within a single sample that spans more than ten orders of magnitude [10].”
Bendall, S. C., Simonds, E. F., Qiu, P., Amir, E.-A. D., Krutzik, P. O., Finck, R., Bruggner, R. V., Melamed, R., Trejo, A., Ornatsky, O. I., et al. (2011) · Science · doi:10.1126/science.1198704 · Cited by 2,279
Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins
Anderson, L., & Hunter, C. L. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500331-mcp200 · Cited by 1,230
Mapping intact protein isoforms in discovery mode using top-down proteomics
Tran, J. C., Zamdborg, L., Ahlf, D. R., Lee, J. E., Catherman, A. D., Durbin, K. R., Tipton, J. D., Vellaichamy, A., Kellie, J. F., Li, M., et al. (2011) · Nature · doi:10.1038/nature10575 · Cited by 665
Self-citationPosttranslational Modification of Pili upon Cell Contact Triggers N. meningitidis Dissemination
Chamot-Rooke, J., Mikaty, G., Malosse, C., Soyer, M., Dumont, A., Gault, J., Imhaus, A.-F., Martin, P., Trellet, M., Clary, G., et al. (2011) · Science · doi:10.1126/science.1200729 · Cited by 180
Augmented Phosphorylation of Cardiac Troponin I in Hypertensive Heart Failure
Dong, X., Sumandea, C. A., Chen, Y.-C., Garcia-Cazarin, M. L., Zhang, J., Balke, C. W., Sumandea, M. P., & Ge, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.293258 · Cited by 99 · cited 2×
“In a recent study, the Ge group observed an increase in phosphorylation in the failing human myocardium by examining the proteoforms of intact cardiac troponin I [34].”
Evaluation of the Compact High-Field Orbitrap for Top-Down Proteomics of Human Cells
Ahlf, D. R., Compton, P. D., Tran, J. C., Early, B. P., Thomas, P. M., & Kelleher, N. L. (2012) · Journal of Proteome Research · doi:10.1021/pr3004216 · Cited by 89
Self-citationMazur, M. T., Cardasis, H. L., Spellman, D. S., Liaw, A., Yates, N. A., & Hendrickson, R. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910776107 · Cited by 87 · cited 2×
“Hendrickson and Yates Coronary artery disease Relative quantification of intact apolipoprotein CIII proteoforms [35]”
Research works printed but not linked: 28
- 10.1002/wsbm.1198 · DOI · Paper page
- 10.1002/emmm.201100198 · DOI
- 10.1373/clinchem.2010.146449 · DOI · Paper page
- 10.1074/mcp.M112.023614 · DOI · Paper page
- 10.1002/prca.201200046 · DOI · Paper page
- 10.1016/j.celrep.2013.01.003 · DOI
- 10.1038/nm.3087 · DOI
- 10.1038/nmeth.2216 · DOI
- 10.1016/j.ab.2006.12.023 · DOI · Paper page
- 10.1074/mcp.M111.008235 · DOI · Paper page
- 10.1074/mcp.M700354-MCP200 · DOI · Paper page
- 10.1373/clinchem.2009.128363 · DOI · Paper page
- 10.1111/j.1464-410X.2011.10568.x · DOI
- 10.1373/clinchem.2008.114686 · DOI · Paper page
- 10.1038/nsmb.2436 · DOI · Paper page
- 10.1038/nmeth.2369 · DOI · Paper page
- 10.1002/elps.1150181133 · DOI · Paper page
- 10.1002/ijc.22041 · DOI
- 10.1074/mcp.M100015-MCP200 · DOI · Paper page
- 10.1073/pnas.160270797 · DOI · Paper page
- 10.1016/S1389-0344(01)00095-8 · DOI
- 10.1021/ac202384v · DOI · Paper page
- 10.1038/nmeth.2074 · DOI · Paper page
- 10.1373/49.8.1276 · DOI
- 10.1021/pr900936z · DOI · Paper page
- 10.1074/jbc.M109.023945 · DOI · Paper page
- 10.1186/gb-2012-13-10-r86 · DOI · Paper page
- 10.1373/clinchem.2010.156976 · DOI
Cited by
How many human proteoforms are there?
Aebersold, R., Agar, J. N., Amster, I. J., Baker, M. S., Bertozzi, C. R., Boja, E. S., Costello, C. E., Cravatt, B. F., Fenselau, C., Garcia, B. A., et al. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2576 · Cited by 907
Self-citationProgress in Top-Down Proteomics and the Analysis of Proteoforms
Toby, T. K., Fornelli, L., & Kelleher, N. L. (2016) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-071015-041550 · Cited by 576
Self-citationBeyond mass spectrometry, the next step in proteomics
Timp, W., & Timp, G. (2020) · Science Advances · doi:10.1126/sciadv.aax8978 · Cited by 302
Li, H., Nguyen, H. H., Ogorzalek Loo, R. R., Campuzano, I. D. G., & Loo, J. A. (2018) · Nature Chemistry · doi:10.1038/nchem.2908 · Cited by 249
“…can directly target protein complexes to obtain structural information beyond a protein’s sequence would allow connections to be made between proteomics and structural biology and potentially yield insights into the dynamics and functional regulations of protein complexes on disease mechanisms 16 .”
Top‐down proteomics in health and disease: Challenges and opportunities
Gregorich, Z. R., & Ge, Y. (2014) · PROTEOMICS · doi:10.1002/pmic.201300432 · Cited by 217
“An emerging “top-down” MS-based proteomics approach, which provides a “bird’s eye” view of all proteoforms present in vivo without a priori knowledge, has unique advantages for the assessment of PTMs and sequence variations and, thus, has great potential for use in biomedical as well as clinical research and probing d…”
Background
Metadata
- Authors
- Savaryn, J. P., Catherman, A. D., Thomas, P. M., Abecassis, M. M., & Kelleher, N. L.
- Venue
- Genome Medicine
- Published
- 2013
- Volume
- 5
- Issue
- 6
- Pages
- 53
- ISSN
- 1756-994X (ISSN-L)
- OpenAlex
- W2014083041
- Cited by
- 102
- References
- 8
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The emergence of top-down proteomics in clinical research. https://app.cochat.ai/papers/10.1186/gm457
- The paper
- Savaryn, J. P., Catherman, A. D., Thomas, P. M., Abecassis, M. M., & Kelleher, N. L. (2013). The emergence of top-down proteomics in clinical research. Genome Medicine. https://doi.org/10.1186/gm457
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.